The efficacy of reboxetine in the treatm
β
P. N. Dannon; I. Iancu; L. Grunhaus
π
Article
π
2002
π
John Wiley and Sons
π
English
β 57 KB
π 2 views
## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the firstβline treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi